Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) Shares Break Above Two Hundred Day Moving Average – Time to Sell?

Fresenius Medical Care AG & Co. KGaA (NYSE:FMS)’s share price passed above its two hundred day moving average during trading on Thursday. The stock has a two hundred day moving average of $22.88 and traded as high as $23.13. Fresenius Medical Care AG & Co. KGaA shares last traded at $23.1050, with a volume of 1,361,082 shares trading hands.

Wall Street Analyst Weigh In

Several equities research analysts recently issued reports on FMS shares. Sanford C. Bernstein upped their price target on Fresenius Medical Care AG & Co. KGaA from $25.50 to $25.80 and gave the company a “market perform” rating in a research report on Thursday, August 6th. Truist Financial decreased their price objective on shares of Fresenius Medical Care AG & Co. KGaA from $25.00 to $24.00 and set a “hold” rating for the company in a report on Monday, October 12th. Berenberg Bank set a $24.00 target price on shares of Fresenius Medical Care AG & Co. KGaA in a research note on Tuesday, September 29th. Zacks Research cut shares of Fresenius Medical Care AG & Co. KGaA from a “hold” rating to a “strong sell” rating in a report on Thursday, October 15th. Finally, Weiss Ratings upgraded shares of Fresenius Medical Care AG & Co. KGaA from a “hold (c)” rating to a “hold (c+)” rating in a research report on Thursday, October 8th. Seven equities research analysts have rated the stock with a Hold rating and four have assigned a Sell rating to the stock. According to MarketBeat, the company presently has an average rating of “Reduce” and an average target price of $23.42.

Fresenius Medical Care AG & Co. KGaA Stock Down 2.8%

The firm has a market cap of $11.97 billion, a price-to-earnings ratio of 11.65, a price-to-earnings-growth ratio of 5.40 and a beta of 0.74. The company has a current ratio of 1.07, a quick ratio of 0.75 and a debt-to-equity ratio of 0.43. The stock has a 50-day moving average of $22.39 and a 200-day moving average of $22.87.

Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) last posted its earnings results on Monday, August 3rd. The company reported $0.66 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.62 by $0.04. Fresenius Medical Care AG & Co. KGaA had a return on equity of 9.28% and a net margin of 4.83%. The company had revenue of $5.55 billion for the quarter, compared to analysts’ expectations of $5.48 billion. As a group, sell-side analysts forecast that Fresenius Medical Care AG & Co. KGaA will post 2.24 EPS for the current fiscal year.

Hedge Funds Weigh In On Fresenius Medical Care AG & Co. KGaA

Hedge funds and other institutional investors have recently made changes to their positions in the business. Tidal Investments LLC raised its stake in Fresenius Medical Care AG & Co. KGaA by 96.0% during the 2nd quarter. Tidal Investments LLC now owns 99,790 shares of the company’s stock valued at $2,256,000 after purchasing an additional 48,885 shares during the period. Moran Wealth Management LLC boosted its position in shares of Fresenius Medical Care AG & Co. KGaA by 31.5% in the first quarter. Moran Wealth Management LLC now owns 347,773 shares of the company’s stock worth $7,846,000 after buying an additional 83,311 shares during the period. Royal Bank of Canada boosted its position in shares of Fresenius Medical Care AG & Co. KGaA by 479.2% in the first quarter. Royal Bank of Canada now owns 216,861 shares of the company’s stock worth $4,893,000 after buying an additional 179,418 shares during the period. Quantinno Capital Management LP grew its holdings in shares of Fresenius Medical Care AG & Co. KGaA by 15.7% during the first quarter. Quantinno Capital Management LP now owns 341,343 shares of the company’s stock valued at $7,701,000 after buying an additional 46,428 shares in the last quarter. Finally, Sei Investments Co. grew its holdings in shares of Fresenius Medical Care AG & Co. KGaA by 80.7% during the first quarter. Sei Investments Co. now owns 120,704 shares of the company’s stock valued at $2,723,000 after buying an additional 53,922 shares in the last quarter. 8.37% of the stock is currently owned by institutional investors and hedge funds.

About Fresenius Medical Care AG & Co. KGaA

Fresenius Medical Care AG & Co KGaA is a Germany-based health care company focused on the treatment of chronic kidney failure. The company provides dialysis care for patients with end-stage renal disease through a network of outpatient dialysis clinics and other health care facilities.

In addition to operating dialysis centers, Fresenius Medical Care develops and supplies products used in dialysis treatment. Its portfolio includes hemodialysis machines, dialyzers, dialysis solutions, bloodlines, and related medical devices and services.